HYPHEN BioMed is a biotechnology company expanding rapidly. Its major activity is designing, developing, manufacturing and marketing in-vitro research and diagnostic reagents for the exploration of Thrombosis, Hemostasis and Auto-Immunity. These reagents are available worldwide, through an extensive network of specialized distributors, or directly from the company (when there is no local distributor).
Our laboratories are equipped with analytical instruments and with highly performing manufacturing equipment. The facility is optimized to the specialized research and production needs of the company. This equipment is continuously evolving in order to adapt to new needs, and manufacturing the new reagents originated from our research.
HYPHEN BioMed owns a complete range of analytical equipment for immunological, clotting and chromogenic methods. The company has also full equipment for cell culture, production of recombinant proteins, engineering and purification of proteins from plasma or biological extracts. Manufacturing machines include various lyophilizers, with a
full capacity of up to 105,000 vials/run, and fully automated filling, capping and labelling lines (20,000 vials/hour).